In this webinar, Chief Scientific Officer Dr. Almudena Pradera (PhD in Pharmacology and Physiology) dives into the science, clinical efficacy, and practical application of HorStem, a licensed equine stem cell therapy.
Dr. Pradera details why newborn umbilical cord tissue serves as the ideal, ethically sound source for pure, non-differentiated mesenchymal stem cells, delivering superior immunomodulatory power and tissue safety. She breaks down the true mechanism of action—explaining that stem cells do not transform into cartilage, but instead reprogram the host’s inflammatory cells at a cellular level to create a long-lasting regenerative environment.
Viewers will also explore impressive data from a 74-horse clinical trial showing extended lameness reduction after a single dose, as well as practical insights on how HorStem functions as a ready-to-use, standard-fridge-stored treatment tailored for everyday equine veterinary practice.
